Advertisement

Reactions Weekly

, Volume 1737, Issue 1, pp 156–156 | Cite as

Icotinib

Development of resistance in lung adenocarcinoma: case report
Case report
  • 12 Downloads

Reference

  1. Zhu Y-C, et al. The KIF5B-RET Fusion Gene Mutation as a Novel Mechanism of Acquired EGFR Tyrosine Kinase Inhibitor Resistance in Lung Adenocarcinoma. Clinical Lung Cancer 20: e73-e76, No. 1, Jan 2019. Available from: URL: http://doi.org/10.1016/j.cllc.2018.09.011 - China

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations